Genmab — December 2019
-
Hvis jeg ikke har misfrostået helt, skulle en af årsagerne til, at pts bliver refraktære over for Dara, netop være, at den udstillede cd38-mængde mindskes - det var der, PD1/PDL-1 hæmmerne kunne opregulere cd38 mængden igen. Så må man vel antage, at isa heller ikke vil virke?
-
Melflufen Dara
https://twitter.com/BertrandBio/status/1203696119705935872 -
Oncopeptides presents promising data from the Phase 2 ANCHOR combination study in patients with RRMM at ASH Annual Meeting 2019
STOCKHOLM — December 8, 2019 — Oncopeptides AB (Nasdaq Stockholm: ONCO) will today present updated
News Powered by Cision (news.cision.com)
-
-
-
https://twitter.com/brianskorney/status/1203704700048199680 Mere på REGN5458.
-
https://twitter.com/drjhoffmanmiami/status/1203718230986149889 Nogen der har en kommentar til denne ?
-
Det er beskrevet i flere guidelines. https://myeloma.hematology.dk/index.php/vejledninger-dmsg/357-m-komponent-analyser-1/file
-
Kan måske mindskes ved indgivelse af immunglobulin. Det kan man få subkutant i hjemmet.
-
Her er abstractet: https://ash.confex.com/ash/2019/webprogram/Paper127247.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind